131 related articles for article (PubMed ID: 37925819)
1. Emerging therapeutic strategy for mitigating cancer progression through inhibition of sirtuin-1 and epithelial-mesenchymal transition.
El-Ashmawy NE; Khedr EG; Khedr NF; El-Adawy SA
Pathol Res Pract; 2023 Nov; 251():154907. PubMed ID: 37925819
[TBL] [Abstract][Full Text] [Related]
2. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.
Choupani J; Mansoori Derakhshan S; Bayat S; Alivand MR; Shekari Khaniani M
J Cell Physiol; 2018 Jun; 233(6):4443-4457. PubMed ID: 29194618
[TBL] [Abstract][Full Text] [Related]
3. The expression of SIRT1 regulates the metastaticplasticity of chondrosarcoma cells by inducing epithelial-mesenchymal transition.
Feng H; Wang J; Xu J; Xie C; Gao F; Li Z
Sci Rep; 2017 Jan; 7():41203. PubMed ID: 28112277
[TBL] [Abstract][Full Text] [Related]
4. Cyanidin-3-glucoside induces mesenchymal to epithelial transition via activating Sirt1 expression in triple negative breast cancer cells.
Liang L; Liu X; He J; Shao Y; Liu J; Wang Z; Xia L; Han T; Wu P
Biochimie; 2019 Jul; 162():107-115. PubMed ID: 30876970
[TBL] [Abstract][Full Text] [Related]
5. SIRT1-ZEB1-positive feedback promotes epithelial-mesenchymal transition process and metastasis of osteosarcoma.
Yu XJ; Guo XZ; Li C; Chong Y; Song TN; Pang JF; Shao M
J Cell Biochem; 2019 Mar; 120(3):3727-3735. PubMed ID: 30304565
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.
Cha BK; Kim YS; Hwang KE; Cho KH; Oh SH; Kim BR; Jun HY; Yoon KH; Jeong ET; Kim HR
Oncotarget; 2016 Aug; 7(35):57213-57227. PubMed ID: 27528025
[TBL] [Abstract][Full Text] [Related]
7. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
8. SIRT1 induces tumor invasion by targeting epithelial mesenchymal transition-related pathway and is a prognostic marker in triple negative breast cancer.
Jin MS; Hyun CL; Park IA; Kim JY; Chung YR; Im SA; Lee KH; Moon HG; Ryu HS
Tumour Biol; 2016 Apr; 37(4):4743-53. PubMed ID: 26515337
[TBL] [Abstract][Full Text] [Related]
9. Suppression of epithelial-mesenchymal transition and SIRT1/AKT signaling pathway in breast cancer by montelukast.
El-Ashmawy NE; Khedr EG; Khedr NF; El-Adawy SA
Int Immunopharmacol; 2023 Jun; 119():110148. PubMed ID: 37044036
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 expression regulates the transformation of resistant esophageal cancer cells via the epithelial-mesenchymal transition.
Qin T; Liu W; Huo J; Li L; Zhang X; Shi X; Zhou J; Wang C
Biomed Pharmacother; 2018 Jul; 103():308-316. PubMed ID: 29656187
[TBL] [Abstract][Full Text] [Related]
11. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
[TBL] [Abstract][Full Text] [Related]
12. ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 and DNMTs during epithelial-to-mesenchymal transition.
Skrypek N; Bruneel K; Vandewalle C; De Smedt E; Soen B; Loret N; Taminau J; Goossens S; Vandamme N; Berx G
Epigenetics Chromatin; 2018 Nov; 11(1):70. PubMed ID: 30445998
[TBL] [Abstract][Full Text] [Related]
13. Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway.
Deng S; Zhu S; Wang B; Li X; Liu Y; Qin Q; Gong Q; Niu Y; Xiang C; Chen J; Yan J; Deng S; Yin T; Yang M; Wu H; Wang C; Zhao G
Cancer Lett; 2014 Dec; 355(2):184-91. PubMed ID: 25172416
[TBL] [Abstract][Full Text] [Related]
14. PIASy mediates hypoxia-induced SIRT1 transcriptional repression and epithelial-to-mesenchymal transition in ovarian cancer cells.
Sun L; Li H; Chen J; Iwasaki Y; Kubota T; Matsuoka M; Shen A; Chen Q; Xu Y
J Cell Sci; 2013 Sep; 126(Pt 17):3939-47. PubMed ID: 23843607
[TBL] [Abstract][Full Text] [Related]
15. Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer.
Wu SM; Jan YJ; Tsai SC; Pan HC; Shen CC; Yang CN; Lee SH; Liu SH; Shen LW; Chiu CS; Arbiser JL; Meng M; Sheu ML
Cell Biol Toxicol; 2023 Oct; 39(5):1873-1896. PubMed ID: 34973135
[TBL] [Abstract][Full Text] [Related]
16. SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis.
Simic P; Williams EO; Bell EL; Gong JJ; Bonkowski M; Guarente L
Cell Rep; 2013 Apr; 3(4):1175-86. PubMed ID: 23583181
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial-mesenchymal transition and modulating SIRT1/β-catenin signaling pathway in breast cancer.
Jin X; Wei Y; Liu Y; Lu X; Ding F; Wang J; Yang S
Cancer Med; 2019 Mar; 8(3):1246-1257. PubMed ID: 30697969
[TBL] [Abstract][Full Text] [Related]
18. SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells.
Sun T; Jiao L; Wang Y; Yu Y; Ming L
Cell Death Dis; 2018 Jan; 9(2):136. PubMed ID: 29374154
[TBL] [Abstract][Full Text] [Related]
19. From the Cover: l-Carnitine via PPARγ- and Sirt1-Dependent Mechanisms Attenuates Epithelial-Mesenchymal Transition and Renal Fibrosis Caused by Perfluorooctanesulfonate.
Chou HC; Wen LL; Chang CC; Lin CY; Jin L; Juan SH
Toxicol Sci; 2017 Dec; 160(2):217-229. PubMed ID: 28973641
[TBL] [Abstract][Full Text] [Related]
20. B7‑H3 promotes the epithelial‑mesenchymal transition of NSCLC by targeting SIRT1 through the PI3K/AKT pathway.
Liao H; Ding M; Zhou N; Yang Y; Chen L
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35029291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]